Trials / Conditions / Desmoplastic Small Round Cell Tumor

Desmoplastic Small Round Cell Tumor

25 registered clinical trials studyying Desmoplastic Small Round Cell Tumor — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190	University of Florida	Phase 1 / Phase 2
Recruiting	Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG NCT07328425	Italian Sarcoma Group	Phase 2
Recruiting	IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986	Fudan University	Phase 2
Recruiting	Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomi NCT06709495	David S Shulman, MD	Phase 1 / Phase 2
Recruiting	Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor NCT06456359	University Hospital Heidelberg	Phase 2
Recruiting	MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154	HRYZ Biotech Co.	Phase 2
Recruiting	Lurbinectedin in FET-Fused Tumors NCT05918640	Children's Hospital of Philadelphia	Phase 1 / Phase 2
Recruiting	B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3 NCT04897321	St. Jude Children's Research Hospital	Phase 1
Unknown	A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) NCT05266196	Salarius Pharmaceuticals, LLC	Phase 1 / Phase 2
Terminated	Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors NCT04901806	Pyramid Biosciences	Phase 1
Recruiting	Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Proje NCT03967834	Institut Claudius Regaud	N/A
Recruiting	Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor NCT04690374	Memorial Sloan Kettering Cancer Center	—
Terminated	Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tum NCT04530487	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT04483778	Seattle Children's Hospital	Phase 1
Active Not Recruiting	CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell T NCT04145349	Eli Lilly and Company	Phase 1 / Phase 2
Withdrawn	Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease NCT01125449	Situs Cancer Research Center	Phase 2
Completed	A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tu NCT04095221	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors NCT04022213	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT03618381	Seattle Children's Hospital	Phase 1
Unknown	Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcom NCT03600649	Salarius Pharmaceuticals, LLC	Phase 1
Unknown	A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma NCT02982486	Assaf-Harofeh Medical Center	Phase 2
Completed	Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors NCT02982941	MacroGenics	Phase 1
Active Not Recruiting	Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors NCT01946529	St. Jude Children's Research Hospital	Phase 2
Unknown	French National Registry of Rare Peritoneal Surface Malignancies NCT02834169	Hospices Civils de Lyon	—
Completed	Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer NCT00436657	M.D. Anderson Cancer Center	Phase 1